Armata Pharmaceuticals (ARMP) Institutional Ownership → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free ARMP Stock Alerts $2.76 +0.23 (+9.09%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Institutional Ownership Changes (13F Filings) for Armata Pharmaceuticals (NYSEAMERICAN:ARMP)CurrentInstitutional OwnershipPercentage3.57%Number ofInstitutional Buyers(last 12 months)1Number ofInstitutional Sellers(last 12 months)0 Get ARMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Armata Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ARMP Institutional Buying and Selling by Quarter Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Armata Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/18/2024 SeaCrest Wealth Management LLC32,777$137K0.0%+80.8%0.091% 11/12/2021Renaissance Technologies LLC106,092$384K0.0%-9.1%0.425% 11/9/2021BlackRock Inc.20,571$74K0.0%+928.0%0.082% 11/8/2021Synovus Financial Corp48,060$174K0.0%+108.4%0.193% 8/17/2021Bridgeway Capital Management LLC113,400$450K0.0%+134.3%0.455% 8/13/2021Renaissance Technologies LLC116,696$463K0.0%-5.8%0.468% 8/13/2021Vanguard Group Inc.167,378$665K0.0%+121.4%0.671% 5/21/2021Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/18/2021Millennium Management LLC15,401$74K0.0%N/A0.062% 5/18/2021Loomis Sayles & Co. L P129,956$621K0.0%N/A0.521% 5/18/2021Citadel Advisors LLC21,306$102K0.0%N/A0.085% 5/13/2021Renaissance Technologies LLC123,816$592K0.0%+25.1%0.496% 5/13/2021Edgewood Management LLC50,000$239K0.0%+25.0%0.200% 5/12/2021Geode Capital Management LLC10,188$48K0.0%N/A0.041% 5/12/2021UBS Group AG6,017$29K0.0%+73.4%0.024% 5/7/2021BlackRock Inc.40,448$194K0.0%+12.4%0.162% 2/10/2021Renaissance Technologies LLC98,996$295K0.0%+5.7%0.529% 2/5/2021BlackRock Inc.35,982$107K0.0%-12.1%0.192% 10/20/2020Wedbush Securities Inc.10,103$32K0.0%N/A0.054% 8/14/2020Bank of America Corp DE633,944$2.49M0.0%+20,583.3%5.802% 5/13/2020Edgewood Management LLC40,000$124K0.0%+100.0%0.366% 5/13/2020 SeaCrest Wealth Management LLC12,655$39K0.0%N/A0.116% (Data available from 1/1/2016 forward) ARMP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ARMP shares? During the previous two years, the following institutional investors and hedge funds held shares of Armata Pharmaceuticals shares: SeaCrest Wealth Management LLC ($137K).Learn more on ARMP's institutional investors. What percentage of Armata Pharmaceuticals stock is owned by institutional investors? 3.57% of Armata Pharmaceuticals stock is owned by institutional investors. Learn more on ARMP's institutional investor holdings. Which institutional investors have been buying Armata Pharmaceuticals stock? The following institutional investors have purchased Armata Pharmaceuticals stock in the last 24 months: SeaCrest Wealth Management LLC ($14.65K). How much institutional buying is happening at Armata Pharmaceuticals? Institutional investors have bought a total of 14,647 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Related Companies: Cardiol Therapeutics Institutional Ownership Outlook Therapeutics Institutional Ownership Vigil Neuroscience Institutional Ownership aTyr Pharma Institutional Ownership bluebird bio Institutional Ownership BioAtla Institutional Ownership Xtant Medical Institutional Ownership Zura Bio Institutional Ownership Agenus Institutional Ownership Omega Therapeutics Institutional Ownership This page (NYSEAMERICAN:ARMP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Armata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
